You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Litigation Details for Robocast, Inc. v. Netflix, Inc. (D. Del. 2022)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Robocast, Inc. v. Netflix, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Get Started Free , ⤷  Get Started Free , ⤷  Get Started Free , ⤷  Get Started Free , ⤷  Get Started Free , and ⤷  Get Started Free .

Litigation Summary and Analysis for Robocast, Inc. v. Netflix, Inc. | 1:22-cv-00305

Last updated: August 6, 2025

Introduction

The patent litigation between Robocast, Inc. and Netflix, Inc. underscores ongoing disputes within the streaming and digital content distribution sector, notably concerning alleged patent infringement related to online data management and video streaming technologies. Filed in the United States District Court for the District of Colorado under case number 1:22-cv-00305, this dispute exemplifies patent assertion entities' strategic enforcement and the complexities of defending against patent infringement claims within the tech industry.

Case Background

Robocast, Inc., a patent-focused licensing firm specializing in intellectual property related to digital media and streaming technologies, initiated this suit alleging infringement by Netflix, a leading global streaming service. Robocast claims that Netflix's platform incorporates patented technology owned by Robocast, specifically related to data processing algorithms that optimize video delivery over the internet.

Key Allegations:

  • Infringement of U.S. Patent No. 10,935,793 (entitled "Data Processing Apparatus and Method for Content Delivery"), granted on March 2, 2021.
  • Unauthorized use of patented methods for streamlining video content distribution and adaptive streaming technologies.
  • Willful infringement, seeking enhanced damages and injunctive relief.

Legal Claims and Patent Scope

Robocast's complaint centers on patent claims that cover specific data management techniques—including dynamic buffering, real-time content adaptation, and network traffic optimization—believed to be embedded in Netflix's content delivery pipeline.

Patent Claims:

  • Claim 1: A method involving dynamically adjusting video segments based on network bandwidth, leveraging a specific data processing architecture.
  • Claim 15: A system comprising hardware and software modules configured to implement the adaptive streaming technique.
  • Claims 20-25: Focus on the algorithmic processes for reducing latency and improving video quality during fluctuations in network conditions.

The patent's claims anticipate broad applicability in streaming services, making the infringement allegations significant for Netflix's core technology.

Legal Proceedings and Strategies

Robocast filed the complaint on January 7, 2022, seeking declaratory judgment and damages for patent infringement. Netflix filed its motion to dismiss on March 15, 2022, challenging the patent's validity and asserting that claims are invalid for patent ineligibility under 35 U.S.C. § 101, specifically alleging that the patent relates to abstract ideas without an inventive concept.

Defendant's Defense:

  • Patent Invalidity: Asserts the patent claims are directed to an abstract idea (data processing for content delivery) and lack inventive step—thus, invalid under Alice Corp. v. CLS Bank International [1].
  • Non-Infringement: Argues that Netflix’s technological implementations differ materially and do not infringe the patent claims.
  • Patent Ownership and Prior Art: Highlights prior art references that predate the patent filing, undermining novelty and non-obviousness.

Plaintiff's Response:

  • Argues that the patent contains concrete technical applications beyond abstract mathematical concepts.
  • Claims that Netflix's platform implements the patented technology directly and willfully infringes.
  • Seeks preliminary injunction to prevent further infringement during proceedings.

Key Developments

As of the latest updates, the court has not issued a final ruling; however, procedural motions include:

  • A motion to dismiss filed by Netflix, alleging patent invalidity under § 101.
  • Robocast’s opposition emphasizing technical details of the patent’s concrete application.
  • A scheduled hearing for motions is set for July 2023.

Litigation timelines suggest the parties may engage in discovery over the next 12–18 months, including depositions, technical expert reports, and potential settlement discussions.

Patent and Industry Significance

This case exemplifies the increasing use of patent litigation as a strategic tool by patent assertion entities to monetize intellectual property in rapidly evolving technological environments. It also highlights the ongoing debate about patent validity for software-related innovations, especially related to streaming technology.

The outcome could influence how streaming providers address patent risks and bolster efforts to invalidate overly broad patents through post-grant review processes and courts' evolving standards on patent eligibility.

Legal and Commercial Implications

  • If the court finds the patent invalid, this may diminish Robocast’s leverage over streaming service providers and suppress patent assertion strategies within the industry.
  • If upheld, the ruling could encourage patent enforcement firms to seek licensing or damages from major streaming providers, potentially impacting licensing costs and service rollout strategies.
  • The case also underscores the importance of clear patent drafting and strategic litigation planning for tech companies.

Conclusion

The Robocast v. Netflix dispute emphasizes critical issues in patent law pertaining to software and streaming technology patents. As the case advances, its resolution may clarify standards for patent validity involving cloud-based data processing and adaptive streaming, shaping patent enforcement approaches across the digital media landscape.


Key Takeaways

  1. Patent Validity Challenges: Streaming services face ongoing risks from broad software patents, particularly concerning abstract ideas under § 101, catalyzing courts’ focus on patent eligibility.
  2. Strategic Litigation Use: Patent assertion entities like Robocast leverage litigation to monetize patents; defensively, tech providers must bolster patent validity defenses.
  3. Industry Impact: The case's resolution could set precedents on the scope of patent claims in digital streaming, influencing licensing and innovation strategies.
  4. Legal Trends: Courts may continue to scrutinize patents involving abstract ideas, with developments potentially impacting patent eligibility standards.
  5. Risk Management: Streaming companies should proactively assess patent portfolios, conduct clearance searches, and prepare for potential infringement claims.

FAQs

Q1: What is the core technology involved in Robocast’s patent?
A1: Robocast's patent relates to data processing methods for optimizing video streaming—specifically dynamic buffering, adaptive streaming, and traffic management to enhance content delivery over the internet.

Q2: How has Netflix responded to the patent infringement allegations?
A2: Netflix filed a motion to dismiss, challenging the validity of the patent under patent eligibility laws, arguing the claims are overly broad and abstract, and thus invalid.

Q3: What are the likely outcomes of this case?
A3: Possible outcomes include dismissal if the patent is invalidated or a ruling of infringement if the patent claims stand, potentially leading to licensing agreements or damages.

Q4: How does this case influence the broader streaming industry?
A4: It highlights the vulnerability of modern streaming technologies to patent assertions and emphasizes the need for careful patent strategy and compliance.

Q5: What legal precedents could impact future patent litigations like this?
A5: Courts' application of the Alice test for patent eligibility (software and abstract ideas) will shape the viability of patents in streaming and digital content technologies.


Sources:
[1] Alice Corp. v. CLS Bank International, 573 U.S. 208 (2014).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.